Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DCGO
DCGO logo

DCGO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy DocGo Inc (DCGO) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast DCGO stock price to rise
4 Analyst Rating
Wall Street analysts forecast DCGO stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.566
sliders
Low
1.5
Averages
3.13
High
4
Current: 0.566
sliders
Low
1.5
Averages
3.13
High
4
Canaccord
Hold
downgrade
$1
AI Analysis
2026-03-25
Reason
Canaccord
Price Target
$1
AI Analysis
2026-03-25
downgrade
Hold
Reason
Canaccord lowered the firm's price target on DocGo to $1 from $1.50 and keeps a Hold rating on the shares. The firm updated is model following mixed Q4 results as revenue topped the high end of its guidance. DocGo has significant work left to do to scale its go-forward Mobile Health business and rightsize its cost structure to regain adj-EBITDA profitability targeted in 2H 2026. The formal process exploring strategic alternatives may deliver a positive outcome for shareholders, but fundamentally, Canaccord maintains its "show me" stance.
Stifel
Buy
maintain
$4
2026-03-17
Reason
Stifel
Price Target
$4
2026-03-17
maintain
Buy
Reason
Stifel lowered the firm's price target on DocGo to $2.50 from $4 and keeps a Buy rating on the shares. Q4 results were mixed and 2026 guidance was raised modestly to reflect improving growth in its transport segment, notes the analyst, who estimates transportation could potentially generate $15M-$20M of 2026 EBITDA pre-overhead and contends that this "implies this unit alone could yield proceeds above current share-price."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DCGO
Unlock Now

People Also Watch